Gerresheimer
Gerresheimer is a prominent global partner to the pharmaceutical and healthcare industries, specializing in the production of specialty glass and plastic products that enhance health and well-being. With approximately 10,000 employees, the company operates manufacturing facilities across Europe, North America, South America, and Asia, generating around EUR 1.4 billion in revenue. Its diverse product portfolio includes pharmaceutical packaging solutions and drug delivery devices, such as insulin pens, inhalers, refillable syringes, injection vials, ampoules, and various containers for both liquid and solid medications. Additionally, Gerresheimer produces packaging for the cosmetics sector and emphasizes innovations in medical technology through its advanced technologies segment. The majority of its revenue is derived from the European market, particularly Germany, reflecting its strong presence in the region.
Bormioli Pharma
Acquisition in 2024
Bormioli Pharma is a manufacturer specializing in primary packaging solutions for the pharmaceutical industry. The company provides a diverse array of childproof and tamper-evident caps and bottles made from materials such as PET, PE, PP, and glass fibers. These packaging products are designed to ensure the safe and efficient storage of medications, protecting them from deterioration and extending their stability. Additionally, Bormioli Pharma's offerings facilitate accurate dosing, contributing to the overall safety and reliability of pharmaceutical products.
Adamant Health
Seed Round in 2022
Adamant Health is a company focused on transforming the management of Parkinson's disease through advanced measurement and analysis technology. Originating from over 15 years of academic research at the University of Eastern Finland, its innovative tools combine electromyography and motion sensor data to provide clinicians with detailed insights into patients' symptoms over several days. This comprehensive visibility allows for optimized treatment plans tailored to individual needs. Additionally, pharmaceutical companies can leverage Adamant Health's objective and long-term real-world data for clinical and post-market studies, using it as a complementary diagnostic tool to enhance personalized medication strategies.
Sensile Medical
Acquisition in 2018
Sensile Medical AG specializes in the development of innovative medical devices for glucose monitoring and micro drug delivery systems. Founded in 2004 and based in Hägendorf, Switzerland, the company creates highly customizable, nanoliter-based devices that enhance patient care and improve quality of life. Sensile Medical's technology focuses on safe and cost-efficient liquid drug delivery solutions, offering both reusable and disposable devices to optimize therapy costs and minimize waste. The company has established strategic partnerships with organizations such as scPharmaceuticals LLC, Sanofi, and Verily, and is recognized for its advancements in on- and off-body drug delivery systems. In 2018, Sensile Medical became a subsidiary of Gerresheimer AG, further expanding its capabilities in the medical device sector.
Centor
Acquisition in 2015
Centor specializes in the manufacture of plastic vials and closures that are used by pharmacies to accurately deliver prescribed medications to patients. The company is dedicated to producing regulatory compliant prescription containers that prioritize safety, aiming to prevent accidental drug ingestions while ensuring ease of use for consumers. Centor adheres to the standards set by the U.S. Consumer Product Safety Commission for child-resistant packaging, reflecting its commitment to both safety and functionality in the pharmaceutical industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.